#GLP-1
3 related articles
GLP-1 Weight-Loss Drugs and Eating Disorders: An Overlooked Risk
GLP-1 weight-loss drugs offer significant benefits but may worsen eating disorder risks. This article explores GLP-1 and eating disorders, self-aware cities, and forever chemicals from The Download newsletter, analyzing the tension between technological breakthroughs and social support systems.
GLP-1 Weight-Loss Drugs and Rising Eating Disorders: Cure or Catalyst?
Global eating disorder incidence rose 71% from 1990-2023, and GLP-1 weight-loss drugs may increase risk. This article explores drug mechanisms, clinical psychology perspectives, and public health challenges, calling for interdisciplinary collaboration and screening.
GLP-1 Weight Loss Drugs and Microdosing Maintenance: Why You Shouldn't Stop Abruptly
GLP-1 drugs like semaglutide shouldn't be stopped abruptly. Learn why cycling on and off worsens body composition, causes muscle loss, and why microdosing maintenance is a smarter strategy.